English
简体中文
Total: £ 56.28
2026-03-20 | Pages: 173 | Tables: 175
The global Custom Metabolite Synthesis Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Custom Metabolite Synthesis Services refer to specialized scientific services pr...
2026-03-20 | Pages: 144 | Tables: 157
The global Dermal Absorption and Penetration Test market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Dermal Absorption and Penetration Test is a scientific method used to evaluate...
2026-03-20 | Pages: 127 | Tables: 138
The global Radiolabelled ADME Studies market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Radiolabelled ADME studies utilize radiolabelled (radioactive) versions of a drug to track...
2026-03-20 | Pages: 184 | Tables: 202
The global Radiolabeling Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Radiolabeling Services involve the process of incorporating radioactive isotopes into molecule...
2026-03-20 | Pages: 124 | Tables: 121
The global Biomedical Monodisperse Microspheres market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global eco...
2026-03-20 | Pages: 103 | Tables: 110
The global Drugs for Controlling Ichthyosis Volvulus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Drugs for Controlling Ichthyosis Volvulus is ...
2026-03-20 | Pages: 102 | Tables: 110
The global Neuronal Regeneration Stem Cell Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Neuronal Regeneration Stem Cell Therapy is proj...
2026-03-20 | Pages: 104 | Tables: 106
The global Limbal Stem Cells Therapies market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The cornea is the eye's major protective barrier and accounts for approximately two- thir...
2026-03-20 | Pages: 116 | Tables: 116
The global Hybridoma Technology market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Hybridoma technology is used to produce monoclonal antibodies (mAbs). It involves fusing B cells...
2026-03-20 | Pages: 101 | Tables: 108
The global Life Science IT Analytics Software market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Life science analytics software refers to specialized tools and platforms designed...
2026-03-20 | Pages: 108 | Tables: 109
The global Life Science Analytics Software market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Life science analytics software refers to specialized tools and platforms designed to...
2026-03-20 | Pages: 116 | Tables: 117
The global Custom Oligonucleotide Synthesis and Gene Synthesis Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.DNA synthesis is the natural or artificial creation of de...
2026-03-20 | Pages: 117 | Tables: 112
The global Custom Oligonucleotide Synthesis and Gene Synthesis market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.DNA synthesis is the natural or artificial creation of deoxyribon...
2026-03-20 | Pages: 115 | Tables: 116
The global Oligonucleotide Synthesis and Gene Synthesis market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.DNA synthesis is the natural or artificial creation of deoxyribonucleic ...
2026-03-20 | Pages: 104 | Tables: 102
The global IHC Primary Antibodies market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for IHC Primary Antibodies is projected to increase from US$ million...
